ATE471336T1 - Das biomolekültransduktionsmotiv mph-1-btm und dessen verwendung - Google Patents
Das biomolekültransduktionsmotiv mph-1-btm und dessen verwendungInfo
- Publication number
- ATE471336T1 ATE471336T1 AT03705417T AT03705417T ATE471336T1 AT E471336 T1 ATE471336 T1 AT E471336T1 AT 03705417 T AT03705417 T AT 03705417T AT 03705417 T AT03705417 T AT 03705417T AT E471336 T1 ATE471336 T1 AT E471336T1
- Authority
- AT
- Austria
- Prior art keywords
- btm
- mph
- transduction motif
- biomolecule transduction
- vaccines
- Prior art date
Links
- 230000026683 transduction Effects 0.000 title abstract 2
- 238000010361 transduction Methods 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 108010041986 DNA Vaccines Proteins 0.000 abstract 1
- 229940021995 DNA vaccine Drugs 0.000 abstract 1
- 229940022005 RNA vaccine Drugs 0.000 abstract 1
- 210000000805 cytoplasm Anatomy 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000002651 drug therapy Methods 0.000 abstract 1
- 210000003527 eukaryotic cell Anatomy 0.000 abstract 1
- 238000001415 gene therapy Methods 0.000 abstract 1
- 239000000367 immunologic factor Substances 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 210000005061 intracellular organelle Anatomy 0.000 abstract 1
- 108700021021 mRNA Vaccine Proteins 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000004940 nucleus Anatomy 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 210000001236 prokaryotic cell Anatomy 0.000 abstract 1
- 238000009163 protein therapy Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 229940126583 recombinant protein vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Transplantation (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Dental Preparations (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020020003183A KR20030062788A (ko) | 2002-01-19 | 2002-01-19 | 생체분자 전달 펩타이드 ｍｐｈ1-ｂｔｍ 및 이것을포함하는 생명공학제품 |
| PCT/KR2003/000122 WO2003059941A1 (en) | 2002-01-19 | 2003-01-20 | Biomolecule transduction motif mph-1-btm and the use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE471336T1 true ATE471336T1 (de) | 2010-07-15 |
Family
ID=36640977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03705417T ATE471336T1 (de) | 2002-01-19 | 2003-01-20 | Das biomolekültransduktionsmotiv mph-1-btm und dessen verwendung |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20050147971A1 (de) |
| EP (1) | EP1468012B1 (de) |
| JP (1) | JP4361371B2 (de) |
| KR (2) | KR20030062788A (de) |
| AT (1) | ATE471336T1 (de) |
| AU (1) | AU2003208020A1 (de) |
| DE (1) | DE60332993D1 (de) |
| ES (1) | ES2347645T3 (de) |
| WO (1) | WO2003059941A1 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20030078115A (ko) * | 2002-03-28 | 2003-10-08 | (주)코아바이오텍 | 펩타이드 유전자 전달매체 및 이를 이용한 유전자 전달 방법 |
| JP4933440B2 (ja) | 2004-11-03 | 2012-05-16 | フォーヒューマンテック・カンパニー・リミテッド | 経皮デリバリーのための薬剤組成物 |
| KR100775958B1 (ko) * | 2005-03-30 | 2007-11-13 | 김정문 | 조직재생 기능을 가지는 비활성 폴리펩티드 및 그 제조방법 |
| EP1863850B1 (de) * | 2005-03-30 | 2009-09-23 | Jung Moon Kim | Nichtaktivierte polypeptide mit einer geweberegenerationsfunktion und verfahren zu ihrer herstellung |
| KR100705981B1 (ko) * | 2005-10-12 | 2007-04-10 | 주식회사 리제론 | 인간 성장호르몬을 포함하는 탈모방지 또는 발모촉진용조성물 |
| EP1942925B1 (de) * | 2005-11-04 | 2010-08-25 | Forhumantech Co., Ltd. | Verfahren zur abgabe von fusionspolypeptid in eine zelle |
| WO2007102631A1 (en) * | 2006-03-07 | 2007-09-13 | Postech Foundation | Novel intracellular transduction peptides |
| WO2008015580A2 (en) | 2006-07-24 | 2008-02-07 | Forhumantech. Co., Ltd. | Pharmaceutical composition for alleviation and treatment of ischemic conditions and method for delivering the same |
| US20080132450A1 (en) * | 2006-08-29 | 2008-06-05 | Forhumantech. Co., Ltd. | Pharmaceutical composition for suppression of apoptosis and method for delivering the same |
| KR100925689B1 (ko) * | 2007-07-25 | 2009-11-10 | 한국생명공학연구원 | 항체와 나노입자를 세포 내로 동시에 전달할 수 있는다기능성 단백질 |
| US7981446B2 (en) * | 2007-11-26 | 2011-07-19 | Forhumantech. Co., Ltd. | Pharmaceutical compositions and methods for delivering nucleic acids into cells |
| KR101278221B1 (ko) * | 2010-06-01 | 2013-06-24 | 연세대학교 산학협력단 | Ρｔｄ－ｕｑｃｒｂ 융합 폴리펩타이드 및 그를 포함하는 허혈성 질환의 예방 및 치료용 약제학적 조성물 |
| CA2804595C (en) | 2010-07-07 | 2018-11-13 | Cellular Dynamics International, Inc. | Endothelial cell production by programming |
| JP6005666B2 (ja) | 2011-02-08 | 2016-10-12 | セルラー ダイナミクス インターナショナル， インコーポレイテッド | プログラミングによる造血前駆細胞の生産 |
| JP6445971B2 (ja) | 2012-05-30 | 2018-12-26 | コーネル ユニヴァーシティー | ヒト羊水由来細胞からの機能的かつ耐久性のある内皮細胞の生成 |
| KR101352759B1 (ko) * | 2013-09-27 | 2014-01-16 | 김대완 | 피시방을 통한 온라인 게임 아이템의 거래중개 방법 |
| CN105462906A (zh) * | 2014-09-11 | 2016-04-06 | 香港理工大学深圳研究院 | 可定植动物肠道的荧光标记大肠杆菌及其制备方法 |
| KR102227966B1 (ko) | 2019-06-26 | 2021-03-16 | 주식회사 엠이티라이프사이언스 | 비활성 폴리펩타이드 ｔｒｐ의 약제학적 제형 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5194596A (en) | 1989-07-27 | 1993-03-16 | California Biotechnology Inc. | Production of vascular endothelial cell growth factor |
| US5350836A (en) | 1989-10-12 | 1994-09-27 | Ohio University | Growth hormone antagonists |
| EP0920508A1 (de) * | 1996-08-23 | 1999-06-09 | Chiron Corporation | Menschliches polyhomeotisch 1 (hph1) wirkt wie ein oncogen |
| US20030104622A1 (en) * | 1999-09-01 | 2003-06-05 | Robbins Paul D. | Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses |
| EP1307594A4 (de) * | 2000-08-04 | 2005-05-25 | Univ Florida Atlantic | Zusammenhang von sim2 und krebs |
| GB0103110D0 (en) * | 2000-08-25 | 2001-03-28 | Aventis Pharma Inc | A membrane penetrating peptide encoded by a nuclear localization sequence from human period 1 |
| KR20030062789A (ko) | 2002-01-19 | 2003-07-28 | 포휴먼텍(주) | 생체분자 전달 펩타이드 ｓｉｍ2-ｂｔｍ 및 이것을포함하는 생명공학제품 |
| JP4229714B2 (ja) * | 2002-09-19 | 2009-02-25 | 株式会社リコー | 画像処理装置、画像処理方法、画像処理プログラム、及び画像処理プログラムを記憶する記憶媒体 |
| KR100591936B1 (ko) | 2002-11-12 | 2006-06-22 | 포휴먼텍(주) | 세포내 ｄｎａ／ｒｎａ 전달 방법, 및 이것의 기초 및임상학적 응용 |
| US7166692B2 (en) | 2003-03-04 | 2007-01-23 | Canbrex Bio Science Walkersville, Inc. | Intracellular delivery of small molecules, proteins, and nucleic acids |
| DK2604286T3 (en) * | 2003-05-01 | 2014-12-08 | Cornell Res Foundation Inc | Method and carrier complex for delivering molecules to cells |
| WO2004113497A2 (en) | 2003-06-09 | 2004-12-29 | University Of Florida | Gene delivery to tumors |
| US20080132450A1 (en) * | 2006-08-29 | 2008-06-05 | Forhumantech. Co., Ltd. | Pharmaceutical composition for suppression of apoptosis and method for delivering the same |
-
2002
- 2002-01-19 KR KR1020020003183A patent/KR20030062788A/ko unknown
-
2003
- 2003-01-20 AU AU2003208020A patent/AU2003208020A1/en not_active Abandoned
- 2003-01-20 KR KR1020047011206A patent/KR100978346B1/ko active IP Right Grant
- 2003-01-20 DE DE60332993T patent/DE60332993D1/de not_active Expired - Lifetime
- 2003-01-20 US US10/501,665 patent/US20050147971A1/en not_active Abandoned
- 2003-01-20 EP EP03705417A patent/EP1468012B1/de not_active Expired - Lifetime
- 2003-01-20 WO PCT/KR2003/000122 patent/WO2003059941A1/en active Application Filing
- 2003-01-20 JP JP2003560043A patent/JP4361371B2/ja not_active Expired - Fee Related
- 2003-01-20 ES ES03705417T patent/ES2347645T3/es not_active Expired - Lifetime
- 2003-01-20 AT AT03705417T patent/ATE471336T1/de not_active IP Right Cessation
-
2005
- 2005-11-07 US US11/267,817 patent/US7700109B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003059941A1 (en) | 2003-07-24 |
| US7700109B2 (en) | 2010-04-20 |
| DE60332993D1 (de) | 2010-07-29 |
| KR100978346B1 (ko) | 2010-08-26 |
| KR20040083429A (ko) | 2004-10-01 |
| AU2003208020A1 (en) | 2003-07-30 |
| ES2347645T3 (es) | 2010-11-03 |
| US20050147971A1 (en) | 2005-07-07 |
| EP1468012A4 (de) | 2005-10-12 |
| JP4361371B2 (ja) | 2009-11-11 |
| KR20030062788A (ko) | 2003-07-28 |
| EP1468012A1 (de) | 2004-10-20 |
| US20060148060A1 (en) | 2006-07-06 |
| JP2005531284A (ja) | 2005-10-20 |
| EP1468012B1 (de) | 2010-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE471336T1 (de) | Das biomolekültransduktionsmotiv mph-1-btm und dessen verwendung | |
| Riminucci et al. | Fibrous dysplasia as a stem cell disease | |
| ATE473235T1 (de) | Das biomolekültransduktionsmotiv sim-2-btm und dessen verwendung | |
| WO2007084342A3 (en) | Codon optimi zed il- 15 and il- 15r-alpha genes for expression in mammalian cells | |
| ATE412761T1 (de) | Methode um rekombinante proteine in cho zellen zu exprimieren | |
| ATE550356T1 (de) | Chimäre t-zellen-rezeptoren sowie entsprechende materialien und verwendungsverfahren | |
| PH12020551039A1 (en) | Non-viral dna vectors and uses thereof for antibody and fusion protein production | |
| NO20020861D0 (no) | PD-1, en reseptor for B7-4, og anvendelser derav | |
| EP4174179A3 (de) | Rna-haltige modifizierte nukleoside und verfahren zur verwendung davon | |
| WO2004022716A3 (en) | Recombinatant mutants of rhabdovirus and methods of use thereof | |
| MY154826A (en) | Fusion protein capable of binding vegf | |
| WO2006007560A3 (en) | Targeted protein replacement for the treatment of lysosomal storage disorders | |
| ATE419358T1 (de) | Gebrauchsverfaheren eines neuen lysyloxidase- verwandten proteins | |
| Callahan et al. | Heat shock up-regulates lmp2 and lmp7 and enhances presentation of immunoproteasome-dependent epitopes | |
| Hosseini et al. | Effect of RGD coupled MDA-7/IL-24 on apoptosis induction in a hepatocellular carcinoma cell line | |
| DK1807518T3 (da) | Rekombinant alfa-fetoprotein, fremgangsmåde og midler til fremstilling heraf, sammensætninger baseret derpå og anvendelse heraf | |
| WO2005034876A3 (en) | Use of cell lines to produce active therapeutic proteins | |
| DE60235985D1 (de) | Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk) | |
| WO2001043693A3 (en) | Polynucleotide vaccines expressing codon optimized hiv-1 nef and modified hiv-1 nef | |
| EP1277843A3 (de) | Neue humane Gene und Genexpressionsprodukte die in Zusammenhang mit Darmkrebs stehen | |
| Xiong et al. | Identification of a functional nuclear localization signal within the human USP22 protein | |
| WO2002014369A3 (en) | Human kininogen d5 domain polypeptides and their use | |
| AU2016216577A1 (en) | Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells | |
| HUP0203801A2 (hu) | Eljárás rekombináns adenovírusok előállítására és adenovírus-könyvtárak | |
| ATE476194T1 (de) | Ein mitglied der menschlichen proteinkinasefamilie, und verwendungen dafür |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |